Agilon Health Inc. (AGL) Misses Q2 EPS by 14c

Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.25), $0.14 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.47 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Star Equity to acquire Harte Hanks for $5.00 per share
• Evolv Technology adds 70 customers in Q2, expands bag screening